Table 1.
Clinical and pathological characteristics of the patients (n = 136).
| Characteristic | No of cases (N) | Percentage (%) | |
|---|---|---|---|
| Age group (years) | ≤50 | 10 | 7.4 |
| >50 | 126 | 92.6 | |
| PSA (ng/ml) | ≤10 | 15 | 11.0 |
| 11–20 | 20 | 14.7 | |
| >20 | 75 | 55.1 | |
| Missing | 26 | 19.1 | |
| Clinical stages | I | 5 | 3.7 |
| II | 24 | 17.6 | |
| III | 56 | 42,2 | |
| IV | 36 | 26.5 | |
| Missing | 15 | 11.0 | |
| Tumour extent | <50% | 54 | 39.7 |
| ≥50% | 82 | 60.3 | |
| GS | 3 + 2 = 5 | 5 | 3.7 |
| 3 + 3 = 6 | 24 | 17.6 | |
| 3 + 4 = 7 | 13 | 9.6 | |
| 4 + 3 = 7 | 18 | 13.2 | |
| 4 + 4 = 8 | 27 | 19.9 | |
| 9 | 34 | 25 | |
| 5 + 5 = 10 | 15 | 11 | |
| GG | GG 1: ≤6 | 29 | 21.3 |
| GG 2: 3 + 4 = 7 | 13 | 9.6 | |
| GG 3: 4 + 3 = 7 | 18 | 13.2 | |
| GG 4: 4 + 4 = 8 | 27 | 19.9 | |
| GG 5: 9-10 | 49 | 36 | |
| Perineural invasion | Present | 58 | 42.7 |
| Absent | 78 | 57.3 | |
| Lymphovascular invasion | Present | 40 | 29.4 |
| Absent | 96 | 70.6 | |
GS: Gleason score, GG: grade grouping, PSA: prostatic-specific antigen.